메뉴 건너뛰기




Volumn 30, Issue 6, 2009, Pages 703-710

Longer (TA)n repeat but not A49T and V89L polymorphisms in SRD5A2 gene may confer prostate cancer risk in South Indian men

Author keywords

5 reductase; Benign prostatic hyperplasia; Dihydrotestosterone; South Indian population; Testosterone

Indexed keywords

ALANINE; GENOMIC DNA; LEUCINE; REPETITIVE DNA; STEROID 5ALPHA REDUCTASE; THREONINE; VALINE;

EID: 70449599769     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: 10.2164/jandrol.108.007377     Document Type: Article
Times cited : (23)

References (38)
  • 1
    • 0032862564 scopus 로고    scopus 로고
    • Somatic mutations at the SRD5A2 locus encoding prostatic steroid 5alpha- Reductase during prostate cancer progression
    • DOI 10.1016/S0022-5347(01)61683-5
    • Akalu A, Dlmajian DA, Highshaw RA, Nichols PW, Reichardt JK. Somatic mutations at the SRD5A2 locus encoding prostatic steroid 5α-reductase during prostate cancer progression. J Urol. 1999;161:1355-1358. (Pubitemid 29426156)
    • (1999) Journal of Urology , vol.161 , Issue.4 , pp. 1355-1358
    • Akalu, A.1    Elmajian, D.A.2    Highshaw, R.A.3    Nichols, P.W.4    Reichardt, J.K.V.5
  • 3
    • 34548217770 scopus 로고    scopus 로고
    • Low-Activity V89L Variant in SRD5A2 Is Associated with Aggressive Prostate Cancer Risk: An Explanation for the Adverse Effects Observed in Chemoprevention Trials Using 5-Alpha-Reductase Inhibitors
    • DOI 10.1016/j.eururo.2007.04.008, PII S030228380700471X
    • Cussenot O, Azzouzi AR, Nicolaiew N, Mangin P, Cormier L, Fournier G, Valeri A, Cancel-Tassin G. Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors. Eur Urol. 2007;52:1082-1087. (Pubitemid 47337033)
    • (2007) European Urology , vol.52 , Issue.4 , pp. 1082-1089
    • Cussenot, O.1    Azzouzi, A.-R.2    Nicolaiew, N.3    Mangin, P.4    Cormier, L.5    Fournier, G.6    Valeri, A.7    Cancel-Tassin, G.8
  • 6
    • 24644440563 scopus 로고    scopus 로고
    • The 5alpha-reductase type II A49T and V89L high-activity allelic variants are more common in men with prostate cancer compared with the general population
    • DOI 10.1016/j.eururo.2005.06.011, PII S0302283805003775
    • Giwercman YL, Abrahamsson PA, Giwercman A, Gadaleanu V, Ahlgren G. The 5alpha-reductase type II A49T and V89L high-activity allelic variants are more common in men with prostate cancer compared with the general population. Eur Urol. 2005;48:679-685. (Pubitemid 41278596)
    • (2005) European Urology , vol.48 , Issue.4 , pp. 679-685
    • Giwercman, Y.L.1    Abrahamsson, P.-A.2    Giwercman, A.3    Gadaleanu, V.4    Ahlgren, G.5
  • 8
    • 2342558431 scopus 로고    scopus 로고
    • Androgen receptor in prostate cancer
    • Heinlein CA, Chang C. Androgen receptor in prostate cancer. Endocr Rev. 2004;25:276-308.
    • (2004) Endocr Rev , vol.25 , pp. 276-308
    • Heinlein, C.A.1    Chang, C.2
  • 13
    • 0035446824 scopus 로고    scopus 로고
    • Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways
    • DOI 10.1002/1097-0142(20010901)92:5<1130::AID-CNCR1430>3.0.CO;2-B
    • Latil AG, Azzouzi R, Cancel GS, Guillaume EC, Cochan-Priollet B, Berthon PL, Cussenot O. Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways. Cancer. 2001;92:1130-1137. (Pubitemid 32861661)
    • (2001) Cancer , vol.92 , Issue.5 , pp. 1130-1137
    • Latil, A.G.1    Azzouzi, R.2    Cancel, G.S.3    Guillaume, E.C.4    Cochan-Priollet, B.5    Berthon, P.L.6    Cussenot, O.7
  • 14
    • 0032846313 scopus 로고    scopus 로고
    • Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2)
    • Lunn RM, Bell DA, Mohler JL, Taylor JA. Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2). Carcinogenesis. 1999;20:1727-1731.
    • (1999) Carcinogenesis , vol.20 , pp. 1727-1731
    • Lunn, R.M.1    Bell, D.A.2    Mohler, J.L.3    Taylor, J.A.4
  • 15
    • 0033936410 scopus 로고    scopus 로고
    • Biochemical and pharmacogenetic dissection of human steroid 5alpha-reductase type II
    • Makridakis NM, di Salle E, Reichardt JK. Biochemical and pharmacogenetic dissection of human steroid 5alpha-reductase type II. Pharmacogenetics. 2000;10:407-413.
    • (2000) Pharmacogenetics , vol.10 , pp. 407-413
    • Makridakis, N.M.1    Di Salle, E.2    Reichardt, J.K.3
  • 18
    • 0035156454 scopus 로고    scopus 로고
    • V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression
    • DOI 10.1016/S0090-4295(00)00928-6, PII S0090429500009286
    • Nam RK, Toi A, Vesprini D, Ho M, Chu W, Harvie S, Sweet J, Trachtenberg J, Jewett MA, Narod SA. V89L polymorphism of type-2, 5-reductase enzyme gene predicts prostate cancer presence and progression. Urology. 2001;57:199-205. (Pubitemid 32065856)
    • (2001) Urology , vol.57 , Issue.1 , pp. 199-204
    • Nam, R.K.1    Toi, A.2    Vesprini, D.3    Ho, M.4    Chu, W.5    Harvie, S.6    Sweet, J.7    Trachtenberg, J.8    Jewett, M.A.S.9    Narod, S.A.10
  • 20
    • 0035474113 scopus 로고    scopus 로고
    • Heterogeneity of genetic alterations in prostate cancer: Evidence of the complex nature of the disease
    • Nwosu V, Carpten J, Trent JM, Sheridan R. Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease. Hum Mol Genet. 2001;10:2313-2318. (Pubitemid 32998847)
    • (2001) Human Molecular Genetics , vol.10 , Issue.20 , pp. 2313-2318
    • Nwosu, V.1    Carpten, J.2    Trent, J.M.3    Sheridan, R.4
  • 21
    • 33847690738 scopus 로고    scopus 로고
    • The association of 5alpha-reductase II (SRD5A2) and 17 hydroxylase (CYP17) gene polymorphisms with prostate cancer patients in the Turkish population
    • DOI 10.1089/dna.2006.0534
    • Onen IH, Ekmekci A, Eroglu M, Polat F, Biri H. The association of 5alpha-reductase II (SRD5A2) and 17 hydroxylase (CYP17) gene polymorphisms with prostate cancer patients in the Turkish population. DNA Cell Biol. 2007;26:100-107. (Pubitemid 46363875)
    • (2007) DNA and Cell Biology , vol.26 , Issue.2 , pp. 100-107
    • Onen, I.H.1    Ekmekci, A.2    Eroglu, M.3    Polat, F.4    Biri, H.5
  • 23
    • 33947246101 scopus 로고    scopus 로고
    • Phenotypic heterogeneity of mutations in androgen receptor gene
    • DOI 10.1111/j.1745-7262.2007.00250.x
    • Rajender S, Singh L, Thangaraj K. Phenotypic heterogeneity of mutations in androgen receptor gene. Asian J Androl. 2007;9:147-179. (Pubitemid 46416577)
    • (2007) Asian Journal of Andrology , vol.9 , Issue.2 , pp. 147-179
    • Rajender, S.1    Singh, L.2    Thangaraj, K.3    Lee, W.M.4
  • 26
    • 21844447090 scopus 로고    scopus 로고
    • Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer
    • DOI 10.1016/j.urolonc.2004.12.014, PII S1078143905000037, Contemporary Clinical Trials in Urologic Oncology
    • Salam MT, Ursin G, Skinner EC, Dessissa T, Reichardt JK. Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer. Urol Oncol. 2005;23:246-253. (Pubitemid 40961936)
    • (2005) Urologic Oncology: Seminars and Original Investigations , vol.23 , Issue.4 , pp. 246-253
    • Salam, M.T.1    Ursin, G.2    Skinner, E.C.3    Dessissa, T.4    Reichardt, J.K.V.5
  • 27
    • 33744824667 scopus 로고    scopus 로고
    • CYP17, SRD5A2, CYP1B1, and CYP2D6 gene polymorphisms with prostate cancer risk in North Indian population
    • DOI 10.1089/dna.2006.25.287
    • Sobti RC, Onsory K, Al-Badran AI, Kaur P, Watanabe M, Krishan A, Mohan H. CYP17, SRD5A2, CYP1B1, and CYP2D6 gene polymorphisms with prostate cancer risk in North Indian population. DNA Cell Biol. 2006;25:287-294. (Pubitemid 43830442)
    • (2006) DNA and Cell Biology , vol.25 , Issue.5 , pp. 287-294
    • Sobti, R.C.1    Onsory, K.2    Al-Badran, A.I.3    Kaur, P.4    Watanabe, M.5    Krishan, A.6    Mohan, H.7
  • 30
    • 0036869078 scopus 로고    scopus 로고
    • CAG repeat expansion in the androgen receptor gene is not associated with male infertility in Indian populations
    • Thangaraj K, Joshi MB, Reddy AG, Gupta NJ, Chakravarty B, Singh L. CAG repeat expansion in the androgen receptor gene is not associated with male infertility in Indian populations. J Androl. 2002;23:815-818. (Pubitemid 36300971)
    • (2002) Journal of Andrology , vol.23 , Issue.6 , pp. 815-818
    • Thangaraj, K.1    Joshi, M.B.2    Reddy, A.G.3    Gupta, N.J.4    Chakravarty, B.5    Singh, L.6
  • 36
    • 0035371666 scopus 로고    scopus 로고
    • Impact of genetic polymorphisms of 17-hydroxylase cytochrome P-450 (CYP17) and steroid 5alpha-reductase type II (SRD5A2) genes on prostate-cancer risk among the Japanese population
    • DOI 10.1002/1097-0215(20010601)92:5<683::AID-IJC1255>3.0.CO;2-4
    • Yamada Y, Watanabe M, Murata M, Yamanaka M, Kubota Y, Ito H, Katoh T, Kawamura J, Yatani R, Shiraishi T. Impact of genetic polymorphisms of 17-hydroxylase cytochrome P-450 (CYP17) and steroid 5α-reductase type II (SRD5A2) genes on prostate cancer risk among the Japanese population. Int J Cancer. 2001;92:683-686. (Pubitemid 32385710)
    • (2001) International Journal of Cancer , vol.92 , Issue.5 , pp. 683-686
    • Yamada, Y.1    Watanabe, M.2    Murata, M.3    Yamanaka, M.4    Kubota, Y.5    Ito, H.6    Katoh, T.7    Kawamura, J.8    Yatani, R.9    Shiraishi, T.10
  • 37
    • 0033059904 scopus 로고    scopus 로고
    • Benign prostatic hyperplasia: An overview
    • Ziada A, Rosenblum M, Crawford ED. Benign prostatic hyperplasia: an overview. Urology. 1999;53:1-6.
    • (1999) Urology , vol.53 , pp. 1-6
    • Ziada, A.1    Rosenblum, M.2    Crawford, E.D.3
  • 38
    • 0028900073 scopus 로고
    • The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation
    • Zubiaga AM, Belasco JG, Greenberg ME. The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol Cell Biol. 1995;15:2219-2230.
    • (1995) Mol Cell Biol , vol.15 , pp. 2219-2230
    • Zubiaga, A.M.1    Belasco, J.G.2    Greenberg, M.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.